ScholarIQanswers from OpenAlex & ORCID
Richard W. Joseph
ResearcherPublications, citations & collaboration network
Richard W. Joseph is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Richard W. Joseph have?
ScholarIQindexed works
Richard W. Joseph has 282 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Richard W. Joseph have?
ScholarIQcitation count
Richard W. Joseph has 25,942 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Richard W. Joseph?
ScholarIQh-index
Richard W. Joseph has an h-index of 53 in OpenAlex.
What is the i10-index of Richard W. Joseph?
ScholarIQi10-index
Richard W. Joseph has an i10-index of 143 in OpenAlex.
What is the ORCID of Richard W. Joseph?
ScholarIQorcid
The ORCID for Richard W. Joseph is on the source record.
What is the OpenAlex record for Richard W. Joseph?
ScholarIQopenalex
The OpenAlex for Richard W. Joseph is on the source record.
What are the most-cited papers on Richard W. Joseph?
ScholarIQmost cited works
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg, Jean Hoffman‐Censits, Tom Powles, Michiel S. van der Heijden, Arjun Vasant Balar, Andrea Necchi, Nancy A. Dawson, Peter H. O’Donnell, Ani Sarkis Balmanoukian, Yohann Loriot, Sandy Srinivas, Margitta Retz, Petros Grivas, Richard W. Joseph, Matthew D. Galsky, Mark T. Fleming, Daniel P. Petrylak, José Luis Perez‐Gracia, Howard A. Burris, Daniel Castellano, Christina Canil, Joaquim Bellmunt, Dean F. Bajorin, Dorothee Nickles, Richard Bourgon, Garrett M. Frampton, Na Cui, Sanjeev Mariathasan, Oyewale O. Abidoye, Gregg Fine, Robert Dreicer
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
David F. McDermott, Mahrukh Huseni, Michael B. Atkins, Robert J. Motzer, Brian I. Rini, Bernard Escudier, Lawrence Fong, Richard W. Joseph, Sumanta K. Pal, James A. Reeves, Mario Sznol, John D. Hainsworth, W. Kimryn Rathmell, Walter M. Stadler, Thomas E. Hutson, Martin Gore, Alain Ravaud, Sergio Bracarda, Cristina Suárez, Riccardo Danielli, Viktor Gruenwald, Toni K. Choueiri, Dorothee Nickles, Suchit Jhunjhunwala, Elisabeth Piault‐Louis, Alpa Thobhani, Jiaheng Qiu, Daniel S. Chen, Priti S. Hegde, Christina Schiff, Gregg Fine, Thomas Powles
High response rate to PD-1 blockade in desmoplastic melanomas
Zeynep Eroglu, Jesse M. Zaretsky, Siwen Hu‐Lieskovan, Dae Won Kim, Alain P. Algazi, Douglas B. Johnson, Elizabeth Liniker, Benjamin Y. Kong, Rodrigo Ramella Munhoz, Suthee Rapisuwon, Pier Federico Gherardini, Bartosz Chmielowski, Xiaoyan Wang, I. Peter Shintaku, Cody Wei, Jeffrey A. Sosman, Richard W. Joseph, Michael A. Postow, Matteo S. Carlino, Wen-Jen Hwu, Richard A. Scolyer, Jane L. Messina, Alistair J. Cochran, Georgina V. Long, Antoni Ribas